CASE REPORT
months of age the infant's electrophoretic pattern was
The propositus was a 965-g female born in September 1971 identical with that of her mother and the variant hemoglobin at 30 weeks' gestation to a 29-year-old gravida 4 mother.
accounted for about 20% of the total. Pregnancy had been uncomplicated until membranes ruptured Since the propositus was a premature infant, 4 days before delivery. The infant was transferred t o Stanford studies were carried out on the adult variant which was university ~~~~i~~l because of prematurity and risk of i isolated chromatographically from the mother's blood. Analy-infection from the premature rupture of membranes. ~h~ sis of the tryptic peptide chromatogram of the ff chain mother had given birth previously to a term male in 1963 and revealed that peptide T-6 was absent; a new peptide was had delivered a male of 26 weeks' gestation who died with isolated at a lower position on the chromatogram. The amino hyaline membrane disease in 1967. A molar pregnancy was acid composition of this peptide revealed that the aspartic acid terminated by dilatation and curretage in 1965. at position 47 was replaced by histidine. Therefore, the ~h , mother was of ltalian, ~~~l i~h , and ~i l i~i~~ mutant hemoglobin was hemoglobin Hasharm (a-47 (CD5) descent and the father was of Cherokee Indian and Irish stock. aspartic acid -+ histidine).
There was no family history of jaundice, bleeding disorders, or Chromatographically prepared hemoglobin F was hybridized splenectomy. An 1 l-year-old niece was anemic and had a with a similar preparation of the adult hemoglobin Hasharon. peptic ulcer. ~f t e r electrophoresis, we found bands corresponding to On initial physical examination the propositus was mildly hemoglobin A and to the fetal hemoglobin Hasharon, as well jaundiced, but there was no pallor or hepatosplenomegaly. as the original hemoglobin F and adult hemoglobin Hasharon. There were occasional episodes of apnea during the first few There were also two bands which migrated anodal to weeks of life which responded to stimulation. During this hemoglobin A which might have been hemoglobin H and period the infant was placed occasionally in oxygen concentrahemoglobin Bart's, representing tetramers of the normal 0 and tions up to 30% in an effort to decrease the frequency of Y chains. These tetramers may have formed because of the apneic episodes. Her clinical course was otherwise unremarkrelative instability of the mutant a: chains.
able.
Speculation
She received a course of penicillin and kananlycin because of the premature rupture of membranes. However, there was The marked hemolytic process in this premature infant was no significant growth in multiple cultures of blood, urine, dependent on the presence of the fetal form of hemoglobin cerebrospinal fluid, and tracheal aspirate, or in maternal Hasharon in fetal erythrocytes. Hemolysis resolved as these amniotic fluid and membranes. cells were replaced by adult-type erythrocytes which conAdmission laboratory data at age 2 days revealed a tained the adult form of hemoglobin Hasharon.
hemoglobin of 14.6 g/100 ml, a packed cell volume of 41.7%, a reticulocyte count of 19.4%, and a white blood count of 32,000/mm3 with a differential of 68% segmented neutrophils, 9% bands, 21% lymphocytes, and 2% monocytes. The peripheral smear showed evidence of a hemolytic process with marked anisocytosis and poikilocytosis, polychromatophilia, stippling, and fragmentation of erythrocytes. The bilirubin was 9.0 mg/100 ml. It rose to a maximum of 11.9 mg/100 ml on the third day of life, and gradually fell to normal values by 4 weeks of age. The direct Coombs test was negative. Both the mother and infant were type A, Rh' . No blood loss was observed clinically. Medications administered during the hospitalization were as follows: penicillin, 100,000 U/kg/24 hr im, and kanamycin, 15 mg/kg/24 hr im, from days 2 through 6 ; calcium gluconate, 50 mg iv on day 3 ; phytonadione, 0.25 mg im on day 5 ; ferrous sulfate, 5 mg elemental iron daily; a vitamin A, C, and D supplement (Tri-Vi-Sol), 0.2 ml daily; and sodium bicarbonate, 2 mEq/kg/24 hr orally from days 18 to 30. Serum vitamin E, as determined by Dr. D. Melhorn, Cleveland, Ohio (1 7), was 0.30 mg/100 ml on day 50. The infant was given 50 mg vitamin E (a-tocopherol acetate) im on day 53 and 5.0 mg daily beginning on day 60. There was no response to this therapy.
During her hospitalization, the baby gained weight in accordance with normal premature standards. Her discharge weight was 2,075 g at age 63 days, which corresponds to a postmenstrual age of 39 weeks. She was clinically well at 7 months of age, at which time her hemoglobin was 12.0 g/100 ml, packed cell volume 34.5%, and reticulocyte count 3.3%.
MATERIALS AND METHODS
Fresh blood was collected with EDTA as anticoagulant. Heinz body preparations were made with 0.5% methyl violet in normal saline. Thermolabile hemoglobin was tested by the method of Dacie et al. (5) in 0.1 M Tris buffer, pH 7.4, at 50'. Glucose 6-phosphate dehydrogenase activity was determined by the method of Motulsky (19) . Electrophoresis was performed on starch gels at pH 8.3 in Tris-EDTA-borate buffer. The proportions of the hemoglobins were determined by starch block electrophoresis using Verona1 buffer, pH 8.6 (14, 15) . Alkali-resistant hemoglobin was determined with standard techniques (14, 27) .
Hemolysates were prepared by the addition of water and toluene t o packed erythrocytes which had been washed three times with isotonic saline. The adult form of hemoglobin Hasharon was chromatographically prepared on an IRC column (14, 25) . The hemolysate was first dialyzed against Developer 6; the same solution was employed to pre-equilibrate the column. Eight milliliters of a 10 g/ 100 ml solution of hemoglobin was placed on the column (1.2 by 30 cm). The column was rinsed with the same developer. Hemoglobin was eluted with a 150 mM sodium phosphate buffer, pH 6.37. Hemoglobin A eluted before hemoglobin Hasharon. The abnormal hemoglobin fraction was vacuum concentrated and its purity confirmed by starch gel electrophoresis.
For identification of the amino acid substitution in this abnormal hemoglobin, the hemolysate was first centrifuged at 20,000 X g for 30 min. The supernatant solution was dialyzed against starting buffer and then subjected to chromatography on DEAE-Sephadex for isolation of the abnormal hemoglobin (9) . Structural analyses were performed by preparation of aminoethylated a chains from globin, column chromatography of the tryptic peptides, and amino acid analyses of the peptides (13, 26) .
Hybridization of hemoglobin Hasharon with chromatographically prepared hemoglobin F was performed according to published methods (6, 12) . The control consisted of a simple mixture 2f the two hemoglobins which was set aside and stored at 4 . Aliquots of the hybridized mixture and of the control were subjected to starch gel electrophoresis at pH 8.6.
RESULTS

INITIAL STUDIES
The variation in hemoglobin and reticulocyte count is plotted in Figure 1 . The hemoglobin fell from an initial value of 15.4 g/100 ml to 10 at 2 weeks of age and to a nadir of 8.5 at 4 weeks of age. The reticulocyte count was about 20% during the first 5 weeks. During the period of elevated reticulocyte count, the peripheral smear continued to show ~ anisocytosis, poikilocytosis, polychromatophilia, and fragmentation of erythrocytes. As the reticulocyte count fell and the hemoglobin rose, the morphology of the erythrocytes gradually approached normal. By 15 weeks of age, there was only minimal anisocytosis. The total serum bilirubin was 9.0 mg/ 100 ml on admission and rose to a high of 1 1.9 mg/ 100 ml , 24 hr after admission. At 11 days of age the bilirubin was 4.1 mg/ 100 ml and at 4 weeks of age it was 1.5 mg/100 ml.
The peripheral smears of both parents and the brother were , unremarkable. Their hemoglobin concentrations, reticulocyte 1 counts, and bilirubin concentrations were normal.
I
Wet Heinz body preparations on the infant's blood were negative on two occasions. Glucose 6-phosphate dehydrogenase activity was normal (decolorization in 37 min; normal adults, 40-60 mi !).
No thermolabile hemoglobin was detected when tested at 50 .
When hemoglobins from this family were electrophoresed, an abnormal pattern was found in the propositus and her mother (Fig. 2) . The mother had a variant hemoglobin with the electrophoretic mobility of hemoglobin S. However, sickle ! preparations were negative at 24 hr, and the hemoglobin was soluble in 2.58 M phosphate buffer, in contrast to hemoglobin S (1 1). The mother's pattern also revealed a faint band running behind A2 and very close to the origin. The distance between this variant and A2 was about the same as the distance between the major variant and A. Such a pattern suggested that the hemoglobin mutation was in the a chain. Examination of the infant's electrophoretic pattern revealed a third variant hemoglobin whose distance from fetal hemoglobin was the same as the distances of the variants in the mother's pattern. hemoglobin. At 11 weeks it was 79%, and at 15 weeks of age was 44%. The electrophoretic pattern at 15 weeks showed an obvious increase in hemoglobin A. It was also between 1 1 and 15 weeks of age that the blood smear became normal. By 7 months of age the infant's electrophoretic pattern was identical with that of her mother. At this time the variant hemoglobin accounted for about 20% of the total in both mother and propositus (Table 1) .
IDENTIFICATION O F MUTATION
Since the propositus was a small premature infant, structural studies were carried out on the adult variant which was isolated chromatographically from the mother's blood. Analysis of the tryptic peptide chromatogram of the a chain revealed that peptide T-6 was absent; a new peptide was isolated at a lower position on the chromatogram. The amino acid composition of this peptide corresponded t o that of the T-6 peptide from normal hemoglobin A except for the absence of aspartic acid and the presence of a n additional residue of histidine. The normal T-6 peptide contains only one aspartic acid residue, a t position 47 (CD5). Therefore the mutant hemoglobin was hemoglobin Hasharon, in which the aspartic acid at position 47 was replaced by histidine. This hemoglobin had been described previously in at least five other families, all of whom were of Jewish descent (3, 7, 26, 28, 29) . There were n o known Jewish ancestors in this family.
HYBRIDIZATION EXPERIMENT
Chromatographically prepared hemoglobin F was hybridized with a similar preparation of the adult hemoglobin Hasharon. 
I
each hemoglobin species present in Figure 3 , but it is clear that the normal hemoglobins A and F are present in greater quantity than the Hasharon forms of A and F.
DISCUSSION
When a chain variants of hemoglobin occur, they are present in significant concentrations a t birth (18) . This contrasts with p chain variants such as hemoglobin S which become quantitatively significant as 0 chain synthesis replaces y chain production during the first months after. birth. We have described a premature infant with a regenerative anemia and jaundice who was heterozygous for the a chain hemoglobin variant, hemoglobin Hasharon. The mild hyperbilirubinemia, anemia, and persistence for several months of reticulocytosis, polychromatophilia, and stippled macrocytes suggested in the absence of blood loss that a compensated hemolytic process existed. Two newborn infants heterozygous for hemoglobin
Hasharon have been previously reported (7, 26) . Their clinical and hematologic picture was not remarkable; however, they were found as part of a cord blood screening program and mild hemolysis might not halie been detected. An older infant has been reported with hemoglobin Hasharon, a hemolytic anemia, and splenomegaly (28) . Although the abnormal hemoglobin was inherited from the father, the hemolytic process may have been due in part t o "an unknown red cell defect perhaps inherited from the mother" who had "a slight increase in bilirubin (1.3 mg/100 ml), a decreased haptoglobin (below 75 mg/100 ml), and a reticulocytosis of 3%" control is a simple mixture of these two hemoglobins. The position of a rapidly migrating, faint band in the hybrid has been outlined by a dashed ellipse.
Hemoglobin Hasharon varies in its clinical manifestations. Adult heterozygotes are usually asymptomatic and have normal hematologic values (4, 7, 26, 29) . However, Charache et al. (4) described a 70-year-old heterozygote who had splenomegaly, gallstones, and a hemolytic anemia with a reticulocyte count of 5%. Study of that patient's family revealed that 9 of 24 persons were carriers but "Hematocrit values, morphological characteristics of red cells, and fetal hemoglobin levels were normal in all family members." Nevertheless, reticulocyte counts were slightly increased in family members who were carriers as compared with noncarriers (2.5% versus 1.3%, which is statistically significant with P less than 0.01). Although autohemolysis and incubated Heinz body preparations were normal, denaturation of hemogloobin Haosharon was greatly increased over hemoglobin A at ,60 or 65 , indicating that hemoglobin Hasharon was less stable than hemoglobin A.
Variability in clinical presentation also occurs with hemoglobin Beilinson in which the aspartic acid a t a-47 is changed t o glycine (21) . Residue 47 is located on the surface of the hemoglobin molecule and is not directly involved in the formation of the heme pocket nor in the a4 chain contact points (20) . However, the detailed quaternary structure of fetal hemoglobin has not yet been determined. With present knowledge one cannot present a convincing molecular explanation for the instability of either the adult or fetal forms of hemoglobin Hasharon (for detailed reviews, see References 1 0 and 24).
One can suggest several explanations for the resolution of the marked hemolysis observed in this premature infant. These include the following: ( 1 ) decreased stability of the fetal hemoglobin Hasharon compared with the adult hemoglobin Hasharon; (2) decreased stability within the environment of the fetal erythrocyte; and (3) or change in the rate of synthesis of the variant hemoglobins.
DECREASED STABILITY OF THE FETAL HEMOGLOBIN HASHARON
increased dissociation leads t o hemolysis in the unstable hemolytic anemias (2) . It is also known that hemoglobin F is less stable than hemoglobin A (1, 2, 16), presumably as a result of the 10-fold greater affinity between a and P chains compared with a and y chains (8) . The interaction of
Hasharon a chains with normal 0 chains must be only minimally decreased (4) . However, the interaction of Hasharon a chains with y chains would be considerably less. Thus the fetal form of hemoglobin Hasharon may be much less stable than the adult form. Such instability could cause hemolytic anemia in this premature infant in whom 80% of the total hemoglobin was fetal type.
DECREASED STABILITY WITHIN FETAL I ERYTHROCYTE
Differences in hemolysis might be a result of the peculiar environment or structure of the fetal erythrocyte itself. Fetal erythrocytes containing either the fetal or adult forms of hemoglobin Hasharon may be more prone t o hemolysis than adult erythrocytes. There are many distinct chemical and metabolic differences between fetal and adult erythrocytes which may contribute t o the increased susceptibility of fetal cells (22, 23) . As discussed above, heat denaturation experiments have demonstrated a subtle decrease in the stability of hemoglobin Hasharon (4); the results of the hybridization experiment (Fig. 3 ) may also be explained b y this decreased stability. A minimal decrease in hemoglobin stability may be insignificant in the adult erythrocyte, but of great import in the fetal erythrocyte. The time course of the hemolytic process in our patient (Fig. 1) is consistent with such an explanation.
CHANGE IN RATE OF SYNTHESIS OF VARIANT CHAIN
As noted in our two heterozygotes, hemoglobin Hasharon usually comprises about 20% of the total hemoglobin (4). Either decreased synthesis or increased destruction or a Hemoglobin can dissociate into globin subunits. These combination of both could account for this lower than 50% subunits are much more susceptible t o denaturation than is concentration. Csarache et al. (4) showed that heterozygotes native hemoglobin (10) . The unstable mutant hemoglobins synthesize only 20-27% of their hemoglobin as Hasharon, have a greater tendency t o dissociate into subunits, and this which demonstrated that decreased synthesis determines the proportion of Hasharon in heterozygotes. The genetics of the a chain are unclear at present (30) . It may be that there are two loci for the a chain; this could account for the presence of 20-25% a chain mutants instead of the 50% which might be expected if there were only a single locus. The rate of synthesis of mutant a chains could change if transcription from these two loci may be varied independently.
Knowing that the adult form of hemoglobin Hasharon is less stable than hemoglobin A, Charache et al. (4) suggested that overt hemolytic anemia might result if the synthesis of hemoglobin Hasharon were increased. It may be that the hemolysis which occurred in our patient was due t o an increased rate of synthesis of the mutant a chain, and that hemolysis resolved as the rate of synthesis of the mutant decreased t o adult levels.
SUMMARY
A premature infant with a hemolytic anemia was found t o be heterozygous for hemoglobin Hasharon (a47 (CD5) aspartic acid -+ histidine), an a chain variant. The hemolysis resolved during the period in which fetal erythrocytes containing the fetal form of the variant hemoglobin were replaced by adult erythrocytes containing the adult form of the variant hemoglobin. By 7 months of age the infant's electrophoretic pattern was identical with that of her mother, who was also a carrier of the variant. The hemolytic anemia in this infant is in contrast t o adults with hemoglobin Hasharon who are general clinically unremarkable.
